Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Recall notice for Sabril 500mg film-coated tablets, PA 540/23/1
Notice type:
Recall
Date:
13/07/2023
We wish to advise you that batch no. 2006B of Sabril 500mg film-coated tablets, PA 540/23/1 is being recalled with immediate effect.
This recall is to pharmacy level.
The recall has been initiated, as a precaution, due to the presence of trace amounts of the impurity tiapride.
Wholesalers can download a copy of the
wholesale recall letter
.
Pharmacist can download a copy of the
pharmacy recall letter
.
As the recall is to pharmacy level, patients are not required to take any actions.
Product name or type:
Sabril 500mg film-coated tablets
Authorisation Number:
PA 540/23/1
Serial Or Batch Number And Expiry Date:
Batch no.2006B, Expiry date: 11.2025
Authorisation Holder:
Sanofi-Aventis Ireland Limited T/A SANOFI, Citywest Business Campus, Dublin 24, Ireland
Recall Classification:
Pharmacy level recall
Target Audience:
Pharmacists and Wholesalers
Actions To Be Taken:
Information for pharmacists:
Pharmacists are requested to carry out the following actions:
1. Immediately identify and quarantine any units from the batch in your facility. For hospital pharmacies, this includes units at wards, clinics and any other relevant locations within the hospital.
2. If you have supplied packs from this batch to any other pharmacy, clinic or other such establishment, please forward a copy of the recall letter to them, and request they quarantine and return any units in their possession to you.
3. Return all quarantined and returned units to your wholesaler.
Information for wholesalers:
Wholesalers are requested to carry out the following actions:
1. Immediately identify and quarantine any units of the batch, which you have in your possession or are returned to you.
2. Identify whether you have supplied units from this batch to any other wholesaler. If you have done so, please forward a copy of this recall letter to those wholesalers, requesting that they immediately quarantine and return any unsold quantities of this batch to you.
3. Return all quarantined and returned units to Allphar before 31 Jul 2023.
Information for patients:
If you are using this product and have any queries, please contact your pharmacist.
« Back
Date Printed: 01/05/2024